In the last trading session, 4.52 million shares of the Arcutis Biotherapeutics Inc (NASDAQ:ARQT) were traded, and its beta was 1.14. Most recently the company’s share price was $9.10, and it changed around -$0.35 or -3.70% from the last close, which brings the market valuation of the company to $1.05B. ARQT currently trades at a discount to its 52-week high of $15.21, offering almost -67.14% off that amount. The share price’s 52-week low was $1.76, which indicates that the current value has risen by an impressive 80.66% since then. We note from Arcutis Biotherapeutics Inc’s average daily trading volume that its 3-month average coming to 4.63 million.
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) trade information
Instantly ARQT has showed a red trend with a performance of -3.70% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 181.73% year-to-date, but still down -10.78% over the last five days. On the other hand, Arcutis Biotherapeutics Inc (NASDAQ:ARQT) is -15.74% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $32, which translates to bulls needing to increase their stock price by 71.56% from its current value. Analyst projections state that ARQT is forecast to be at a low of $8 and a high of $51.
Arcutis Biotherapeutics Inc (ARQT) estimates and forecasts
Arcutis Biotherapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 181.73 percent over the past six months and at a 34.13% annual growth rate that is well above the industry average of 13.30%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -48.07%. Arcutis Biotherapeutics Inc earnings are expected to increase by 37.10% in 2024, but the outlook is positive 9.80% per year for the next five years.
ARQT Dividends
Arcutis Biotherapeutics Inc’s next quarterly earnings report is expected to be released around May 07 and May 13.
